Tech Company Financing Transactions
Orexigen Therapeutics Funding Round
Orexigen Therapeutics closed a $165 million funding round on 3/29/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
3/29/2016
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$165,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 21 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3344 N. Torrey Pines Ct. 200
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
OREXIGEN is studying a novel, and potentially more effective way, to achieve and sustain weight loss through a combined, two-drug approach.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Narachi
Chief Financial Officer
Monica Forbes
Chief Operating Officer
Thomas Cannell
VP - Bus. Development
Peter Flynn
VP - General Counsel
Thomas Lynch
Browse more venture capital transactions:
Prev: 3/29/2016: Havenly venture capital transaction
Next: 3/29/2016: Bauxy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs